Constantiam Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Constantiam Biosciences's estimated annual revenue is currently $1.7M per year.
- Constantiam Biosciences's estimated revenue per employee is $155,000
Employee Data
- Constantiam Biosciences has 11 Employees.
- Constantiam Biosciences grew their employee count by 10% last year.
Constantiam Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CCO | Reveal Email/Phone |
2 | Co-Founder and CSO | Reveal Email/Phone |
3 | Director, Computational Biology | Reveal Email/Phone |
4 | Director, Functional Genomics | Reveal Email/Phone |
Constantiam Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.5M | 16 | 45% | N/A | N/A |
#2 | $13.8M | 89 | -7% | N/A | N/A |
#3 | $18.6M | 120 | 3% | $1.8M | N/A |
#4 | $0.9M | 6 | -40% | N/A | N/A |
#5 | $4.2M | 27 | 0% | N/A | N/A |
#6 | $3.4M | 22 | 47% | N/A | N/A |
#7 | $9.6M | 62 | 29% | N/A | N/A |
#8 | $0.9M | 6 | 20% | N/A | N/A |
#9 | $1.7M | 11 | 10% | N/A | N/A |
#10 | $15.2M | 98 | -8% | N/A | N/A |
What Is Constantiam Biosciences?
MAVEvidence is the premier functional evidence resource for the clinical genetics community. MAVEvidence delivers increased productivity and time savings through comprehensive curation, rigorous analysis, and clear presentation of functional evidence derived from high-throughput studies of genetic variants. The MAVEvidence platform contains more than 187,000 pieces of evidence across 125,000 genetic variants, and is continually updated with data from the latest functional studies.
keywords:N/AN/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 11 | 0% | $3M |
#2 | $1M | 11 | N/A | N/A |
#3 | $1M | 11 | N/A | N/A |
#4 | $1M | 11 | N/A | N/A |
#5 | $1.3M | 11 | N/A | N/A |